Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
9312199 | Urology | 2005 | 5 Pages |
Abstract
The results of our study have shown that in the short term, RFA appears to be a reasonable therapeutic nephron-sparing approach for treating select patients with small renal tumors. The cancer control appears adequate to date, but longer follow-up is necessary before widespread application.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Edward D. Matsumoto, D. Brooke Johnson, Kenneth Ogan, Clayton Trimmer, Arthur Sagalowsky, Vitaly Margulis, Jeffrey A. Cadeddu,